Section one: Contracting authority
one.1) Name and addresses
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK10 4TG
Contact
Mr Kieran McGowan
Kieran.McGowan@md.catapult.org.uk
Telephone
+44 1625708394
Country
United Kingdom
NUTS code
UKD62 - Cheshire East
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Other activity
Research
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Validation Centre: Appointment of Main Contractor, Design & Management Teams
two.1.2) Main CPV code
- 45210000 - Building construction work
two.1.3) Type of contract
Works
two.1.4) Short description
Medicines Discovery Catapult (MDC) is conducting market engagement/research for the establishment of Contracts for a Main Contractor, Design & Management Team disciplines relating to a Validation Laboratory. A brief questionnaire relating to this exercise is attached with this link. Please respond via this link. https://procontract.due-north.com/Procurer/Advert/View?advertId=d92dff00-f266-eb11-8108-005056b64545&fromAdvertEvent=True
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKD62 - Cheshire East
two.2.4) Description of the procurement
Medicines Discovery Catapult (MDC) are a national facility for collaborative R and D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Medicines Discovery Catapult (MDC) is conducting market engagement/research for the establishment of Contracts for a Main Contractor and Design Team disciplines relating to a Validation Laboratory. A brief questionnaire relating to this exercise can be found at Appendix 1. MDC is seeking the input of the marketplace on a number of areas to help inform the structure of the Contracts and the scope of requirement.
Completion of this questionnaire and any involvement in this market engagement does not confer any right or expectation that the organisation will be selected for any further tender should a procurement exercise be undertaken.
By participating in the market engagement questionnaire, you are undertaking that you are authorised to supply any information you provide, and that you understand and agree that:
— Participation in this market engagement will not include or preclude any organisation from participating in any future procurement exercise,
— The outcome of the market engagement will aid MDC’s development of its procurement strategy and will not favour any single response to the market engagement,
— No information provided in the response to the market engagement will be used in any evaluation of any subsequent response to a procurement exercise,
— The outcomes of the market engagement will become the sole property of MDC; and
— MDC reserves the right to disclose the outcomes of the market engagement with Innovate UK and partner Catapults.
The deadline for completing and returning this questionnaire is 16:00 on 18/02/2021. Please respond via this e-tendering portal https://procontract.due-north.com/Procurer/Advert/View?advertId=d92dff00-f266-eb11-8108-005056b64545&fromAdvertEvent=True.
two.2.6) Estimated value
Value excluding VAT: £4,000,000
two.3) Estimated date of publication of contract notice
31 March 2021
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes